Research Dossier vs. Literature Review vs. Research Report: What Each Term Actually Means

The difference between a research dossier, a literature review, and a research report looks like a glossary problem. It's a planning problem. Confuse them and the bill lands as a bounced submission, a wasted quarter, or a review that has to be redone from the top because nobody stated the method.

Ask a room of analysts, policy researchers, and clinical evaluation teams to define the three terms and you'll get eleven answers — one of them probably a funding call that asked for the wrong document in the first place. The terms aren't three names for the same artefact. A research dossier exists to support a decision, a literature review exists to map what is already known, and a research report exists to document new findings in a form another team can check. Each has its own audience, its own quality bar, and its own characteristic way of failing when the format slips.

Three documents, three jobs

Start with the job each document is hired to do. Purpose dictates format, and format is where most of the trouble hides.

The research dossier: a case file for a decision

A research dossier is a curated package of evidence assembled for a specific decision and a specific reader. It is defined by purpose, not by any universal outline. The cleanest example is pharmaceutical regulation: a marketing-authorisation application is built as a Common Technical Document (CTD), the harmonised five-module format used across the International Council for Harmonisation (ICH) regions. The modules hold administrative information, summaries, quality data, non-clinical study reports, and clinical study reports — and regulators warn that the format cannot be changed once an application is submitted. In the United States, health insurers read a different dossier standard, the AMCP Format for Formulary Submissions, which lays out the clinical and economic evidence a manufacturer should present to a health care decision-maker. The same logic runs through due diligence and policy work: a dossier gathers whatever evidence the decision requires, in the structure the decision-maker expects.

The literature review: a map of what's already known

A literature review synthesises published work on a question. Its raw material is other people's studies, published reports, and secondary datasets — never new data of your own. The label spans a wide range of rigour. A narrative review offers an expert overview and may never disclose its search method. A systematic review follows a predefined protocol, searches multiple databases, screens records against explicit inclusion criteria, and assesses the risk of bias in each included study; Cochrane reviews, which inform health decisions around the world, are systematic reviews. A meta-analysis goes further and statistically pools results from comparable studies. The telling question is always the same: could someone else reproduce the search and end up with the same set of studies? If not, it's a well-referenced opinion piece.

The research report: the record of new evidence

A research report documents original research — data you collected yourself, generated, or measured. In technical and scientific fields it usually follows the IMRAD structure: Introduction, Methods, Results, and Discussion. The Methods section is the credibility test; it should let another team reproduce the study. Government agencies and consultancies produce research reports as the auditable record of what was done and what was found. And here's the tangle: a report's introduction will usually carry a short literature review. The review is a section inside the report, not the report itself.

Why the three get confused — and what it costs

Part of the confusion is structural: the documents nest inside one another. A research report opens with a literature review. A dossier may include study reports and review summaries as exhibits. The same text can be a literature review in one context and a single component of a dossier in another. That's not the terms failing; it's the terms describing different levels of the same stack.

The rest of the confusion is habit. "Review" sounds lighter than "report," so people reach for it when they mean a quick scan. "Dossier" sounds heavier, so it gets applied to any folder of PDFs. Neither instinct survives contact with a decision-maker. A health-technology dossier missing its economic model gets sent back. A "systematic review" with no protocol or search strategy is a long annotated bibliography. A report whose Methods section can't support replication is a story, not evidence.

The costs are concrete. Manufacturers spend months assembling a dossier to a fixed format, and a single misplaced module delays a submission. A funder that receives a study report after commissioning a literature review has paid for the wrong thing — a map of the field, not another dataset. And every mislabelled document trains the next reader to distrust the label.

Here's the catch

Here's the catch: the boundary between these documents isn't the content. It's the controlling purpose and the audience, and you can't infer either from the title. The useful question isn't "is this a dossier or a review or a report?" It's "what is this for, and who has to act on it?" A review written to a regulator's deadline carries different obligations than a review written for a team's internal planning. A dossier built for a formulary committee follows a specified section structure; a dossier built for a client's board follows whatever the client asked for. Same word, different document.

Then there's the label problem. "Literature review" is the most abused term of the three, because anything with a reference list can wear it. The PRISMA 2020 statement exists precisely because of that slippage: its 27-item checklist is not bureaucracy, it's a way to let a reader judge whether the methods support the findings. If a review can't state its search strategy, its inclusion criteria, and how it judged risk of bias, call it what it is — background reading. Honesty travels further than a borrowed label.

Versioning matters too. Dossiers are living documents, and a business or regulatory dossier is only as good as its research cutoff date. Update it before the decision, not after.

Hype versus reality

The labels invite grand claims. Strip them back and the practical differences show up fast.

Build the right one, not the longest one

A few questions usually settle which document you're actually writing.

• Are you presenting findings from data you collected or generated? Write a research report, and make the Methods section the most detailed part.
• Are you mapping published evidence to answer a question? Write a literature review — systematic if the answer will be audited, narrative if it's internal orientation.
• Are you assembling evidence so a specific audience can make a specific decision? Build a dossier, and get the required format before you write a word.
• Will the document need to stay live after the deadline? Then date it, version it, and record the research cutoff so the next reader knows what it can still claim.

If the document must persuade a decision-maker, follow the format exactly — in regulated settings the format is part of the requirement, not a suggestion. The Common Technical Document used for medicines approvals is the extreme case: five modules, fixed order, no changes after submission. If the document must survive scrutiny, publish the method; for systematic reviews that means following guidance such as the Cochrane Handbook and reporting against PRISMA. If it documents original work, treat reproducibility as the acceptance test. The AMCP Format for Formulary Submissions shows the dossier end of the spectrum: its fifth edition, released in April 2024, pushed for shorter, sharper submissions because decision-makers complained that dossiers had grown too long.

None of this is about making prettier documents. It's about making documents that can be trusted, checked, and acted on with confidence. The authors of the PRISMA 2020 statement put the standard plainly: complete reporting "allows readers to assess the appropriateness of the methods, and therefore the trustworthiness of the findings." That's the test for a dossier, a review, or a report of original findings. If the reader can't see how you got there, the document hasn't done its job.

Photo by Daria Nepriakhina 🇺🇦 on Unsplash